pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
425
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
Gliflozins
Congestive Heart Failure (Heart Failure)
$RTX
RTX Corp
0
catalysts
Preclinical
Glunozumab
Unspecified
Lys Therapeutics SAS
0
catalysts
Preclinical
Granulocyte Colony-Stimulating-Factor (G-CSF)
Thromboangiitis obliterans (Buerger disease)
Vasogenesis Inc
0
catalysts
Phase 2
HBI-3000
← prev
page 6 of 15
next →
131
Pain
89
Neurology
1
Atrial Fibrillation
HUYA Bioscience International LLC
0
catalysts
Phase 2
HUNS-001
Cerebral Infarction (Brain Infarction)
Rainbow Inc
0
catalysts
Preclinical
HY-074
Acute Coronary Syndrome
Hyloris Pharmaceuticals SA
0
catalysts
Preclinical
HY-075
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Hyloris Pharmaceuticals SA
0
catalysts
Phase 2
HeXell-2020
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Hexun Bioscience Co Ltd
0
catalysts
Preclinical
ISX9-CPC
Cardiomyopathy
IPS Heart Inc
0
catalysts
Phase 3
IkT-001
Pulmonary Arterial Hypertension
$IKT
Inhibikase Therapeutics, Inc.
0
catalysts
Marketed
Intropin
Dopamine Hydrochloride (dopamine hydrochloride)
Hemorrhagic Shock
$PFE
PFIZER INC
0
catalysts
Preclinical
JBTmiR-2
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Jaan Biotherapeutics Inc
0
catalysts
Phase 2
JK-07
Diastolic Heart Failure (HFpEF)
Salubris Biotherapeutics Inc
0
catalysts
Preclinical
K-130
Neurogenic Orthostatic Hypotension (nOH)
$AMRX
Amneal Pharmaceuticals, Inc.
0
catalysts
Phase 3
KPL-387
Pericarditis
$KNSA
Kiniksa Pharmaceuticals International, plc
0
catalysts
Phase 2
LX-2006
Cardiomyopathy
$LXEO
Lexeo Therapeutics, Inc.
0
catalysts
Phase 2
LX-2020
Cardiomyopathy
$LXEO
Lexeo Therapeutics, Inc.
0
catalysts
Marketed
Lotensin HCT
Benazepril Hydrochloride + Hydrochlorothiazide + Rising ((benazepril hydrochloride + hydrochlorothiazide [INN]))
Hypertension
Rising Pharma Holdings Inc
0
catalysts
Preclinical
M-9i
Acute Ischemic Stroke
Translational Sciences Inc
0
catalysts
Phase 2
MANP
Resistant Hypertension
E-Star BioTech LLC
0
catalysts
Marketed
Micardis HCT
Micardis HCT ((hydrochlorothiazide [INN] + telmisartan))
Hypertension
Boehringer Ingelheim Corp
0
catalysts
Phase 2
Motrem
Septic Shock
Triggering receptor expressed on myeloid cells 1
Inotrem SA
0
catalysts
Phase 2
Mydicar
Systolic Heart Failure (HFrEF)
Sardocor Corp
0
catalysts
Phase 2
NCS-01
Acute Ischemic Stroke
NC Medical Research Inc
0
catalysts
Preclinical
NIV-001
Stroke
Neuro-Innovators LLC
0
catalysts
Preclinical
NOVS-100
Obesity
Celloram Inc
0
catalysts
Preclinical
NP-6A
Cardiomyopathy
Novopyxis Inc
0
catalysts
Phase 1
NTP-42
Pulmonary Arterial Hypertension
ATXA Therapeutics Ltd
0
catalysts
Phase 1
NTS-1104
Acute Ischemic Stroke
NeuroTrauma Sciences LLC
0
catalysts
Phase 2
NVX-108
perflenapent
Glioblastoma Multiforme (GBM)
NuvOx Pharma LLC
0
catalysts
